Indivior Share Price | |
---|---|
Price | 1,432.00 |
Bid | 1,438.00 |
Ask | 1,440.00 |
Change | 5.00 (0.35%) |
Volume | 162,852 |
Open | 1,425.00 |
High | 1,443.00 |
Low | 1,423.00 |
Prev. Close | 1,427.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.26m |
Market Capitalisation | £1.94b |
Market Size | 500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 650 |
---|---|
Vol. Sold | 116,985 |
Sold Value | £1.68m |
Vol. Bought | 43,350 |
Bought Value | £622.63k |
PE Ratio | 1,823.21441 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
10-May-24 | 18:05:08 | 1,429.62081 | 200 | Unknown* | 1,438.00 | 1,440.00 | 2,859 | O Ordinary Was reported as OTC |
10-May-24 | 16:51:25 | 1,432.00 | 468 | Unknown* | 1,438.00 | 1,440.00 | 6,702 | O Ordinary |
10-May-24 | 16:35:26 | 1,432.00 | 82,380 | Sell* | 1,438.00 | 1,440.00 | 1m | UT Uncrossing Trade |
10-May-24 | 16:29:59 | 1,438.00 | 124 | Sell* | 1,438.00 | 1,440.00 | 1,783 | A Automatic Execution |
10-May-24 | 16:29:49 | 1,440.00 | 185 | Buy* | 1,438.00 | 1,440.00 | 2,664 | O Ordinary Trade was executed as an SI |
10-May-24 | 16:29:16 | 1,438.00 | 34 | Sell* | 1,438.00 | 1,440.00 | 488.92 | A Automatic Execution |
10-May-24 | 16:29:16 | 1,438.00 | 158 | Sell* | 1,438.00 | 1,440.00 | 2,272 | A Automatic Execution |
10-May-24 | 16:29:16 | 1,438.00 | 242 | Sell* | 1,438.00 | 1,440.00 | 3,480 | A Automatic Execution |
10-May-24 | 16:23:36 | 1,439.00 | 33 | Buy* | 1,438.00 | 1,439.00 | 474.87 | A Automatic Execution |
10-May-24 | 16:23:35 | 1,439.00 | 57 | Buy* | 1,438.00 | 1,439.00 | 820.23 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.